These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 8381639)

  • 1. Coumermycin A1 inhibits growth and induces relaxation of supercoiled plasmids in Borrelia burgdorferi, the Lyme disease agent.
    Samuels DS; Garon CF
    Antimicrob Agents Chemother; 1993 Jan; 37(1):46-50. PubMed ID: 8381639
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic transformation of the Lyme disease agent Borrelia burgdorferi with coumarin-resistant gyrB.
    Samuels DS; Mach KE; Garon CF
    J Bacteriol; 1994 Oct; 176(19):6045-9. PubMed ID: 7928965
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novobiocin and coumermycin inhibit DNA supercoiling catalyzed by DNA gyrase.
    Gellert M; O'Dea MH; Itoh T; Tomizawa J
    Proc Natl Acad Sci U S A; 1976 Dec; 73(12):4474-8. PubMed ID: 794878
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gyrase inhibitors can increase gyrA expression and DNA supercoiling.
    Franco RJ; Drlica K
    J Bacteriol; 1989 Dec; 171(12):6573-9. PubMed ID: 2556367
    [TBL] [Abstract][Full Text] [Related]  

  • 5. gyrB mutations in coumermycin A1-resistant Borrelia burgdorferi.
    Samuels DS; Marconi RT; Huang WM; Garon CF
    J Bacteriol; 1994 May; 176(10):3072-5. PubMed ID: 8188609
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estimation of the effect of coumermycin A1 on Salmonella typhimurium promoters by using random operon fusions.
    Jovanovich SB; Lebowitz J
    J Bacteriol; 1987 Oct; 169(10):4431-5. PubMed ID: 2820924
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Directed insertion of a selectable marker into a circular plasmid of Borrelia burgdorferi.
    Rosa P; Samuels DS; Hogan D; Stevenson B; Casjens S; Tilly K
    J Bacteriol; 1996 Oct; 178(20):5946-53. PubMed ID: 8830691
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of novobiocin, coumermycin A1, clorobiocin, and their analogs on Escherichia coli DNA gyrase and bacterial growth.
    Hooper DC; Wolfson JS; McHugh GL; Winters MB; Swartz MN
    Antimicrob Agents Chemother; 1982 Oct; 22(4):662-71. PubMed ID: 6295263
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coumarin and quinolone action in archaebacteria: evidence for the presence of a DNA gyrase-like enzyme.
    Sioud M; Possot O; Elie C; Sibold L; Forterre P
    J Bacteriol; 1988 Feb; 170(2):946-53. PubMed ID: 2828337
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Positively supercoiled plasmid DNA is produced by treatment of Escherichia coli with DNA gyrase inhibitors.
    Lockshon D; Morris DR
    Nucleic Acids Res; 1983 May; 11(10):2999-3017. PubMed ID: 6304617
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential sensitivity of gene expression in vitro to inhibitors of DNA gyrase.
    Yang HL; Heller K; Gellert M; Zubay G
    Proc Natl Acad Sci U S A; 1979 Jul; 76(7):3304-8. PubMed ID: 226966
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mycobacterial DNA gyrase: enzyme purification and characterization of supercoiling activity.
    Wu LC; Shahied SI
    Arch Biochem Biophys; 1995 Dec; 324(1):123-9. PubMed ID: 7503546
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oligonucleotide-mediated genetic transformation of Borrelia burgdorferi.
    Samuels DS; Garon CF
    Microbiology (Reading); 1997 Feb; 143 ( Pt 2)():519-522. PubMed ID: 9043127
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discrepancy between the antibacterial activities and the inhibitory effects on Micrococcus luteus DNA gyrase of 13 quinolones.
    Fu KP; Grace ME; McCloud SJ; Gregory FJ; Hung PP
    Chemotherapy; 1986; 32(6):494-8. PubMed ID: 3026740
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resistance genes of aminocoumarin producers: two type II topoisomerase genes confer resistance against coumermycin A1 and clorobiocin.
    Schmutz E; Mühlenweg A; Li SM; Heide L
    Antimicrob Agents Chemother; 2003 Mar; 47(3):869-77. PubMed ID: 12604514
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcriptional regulation of the ospAB and ospC promoters from Borrelia burgdorferi.
    Alverson J; Bundle SF; Sohaskey CD; Lybecker MC; Samuels DS
    Mol Microbiol; 2003 Jun; 48(6):1665-77. PubMed ID: 12791146
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of bacterial DNA gyrase inhibitors on DNA synthesis in mammalian mitochondria.
    Castora FJ; Vissering FF; Simpson MV
    Biochim Biophys Acta; 1983 Sep; 740(4):417-27. PubMed ID: 6309236
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanism of inhibition of vaccinia DNA topoisomerase by novobiocin and coumermycin.
    Sekiguchi J; Stivers JT; Mildvan AS; Shuman S
    J Biol Chem; 1996 Jan; 271(4):2313-22. PubMed ID: 8567695
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fluoroquinolone-dependent DNA supercoiling by Vaccinia topoisomerase I.
    Kamau E; Grove A
    J Mol Biol; 2004 Sep; 342(2):479-87. PubMed ID: 15327948
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Linear- and circular-plasmid copy numbers in Borrelia burgdorferi.
    Hinnebusch J; Barbour AG
    J Bacteriol; 1992 Aug; 174(16):5251-7. PubMed ID: 1644750
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.